NANOG and prostate carcinoma: Notably, SPOP mutants derived from prostate cancer were found to cluster in their substrate-recruited MATH structural domains, thereby disrupting SPOP's ability to bind to and promote Nanog for polyubiquitination and degradation, ultimately suppressing the characterization of prostate CSCs.